𝔖 Bobbio Scriptorium
✦   LIBER   ✦

In vitro release of vascular endothelial growth factor from gadolinium-doped biodegradable microspheres

✍ Scribed by Anthony Z. Faranesh; Monet T. Nastley; Cristina Perez de la Cruz; Michael F. Haller; Patrice Laquerriere; Kam W. Leong; Elliot R. McVeigh


Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
245 KB
Volume
51
Category
Article
ISSN
0740-3194

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

A drug delivery vehicle was constructed that could be visualized noninvasively with MRI. The biodegradable polymer poly(DL‐lactic‐co‐glycolic acid) (PLGA) was used to fabricate microspheres containing vascular endothelial growth factor (VEGF) and the MRI contrast agent gadolinium diethylenetriamine pentaacetic acid (Gd‐DTPA). The microspheres were characterized in terms of size, drug and contrast agent encapsulation, and degradation rate. The PLGA microspheres had a mean diameter of 48 ± 18 μm. The gadolinium loading was 17 ± 3 μg/mg polymer and the VEGF loading was 163 ± 22 ng/mg polymer. Electron microscopy revealed that the Gd was dispersed throughout the microspheres and it was confirmed that the Gd loading was sufficient to visualize the microspheres under MRI. VEGF and Gd‐DTPA were released from the microspheres in vitro over a period of ∼6 weeks in three phases: a burst, followed by a slow steady‐state, then a rapid steady‐state. Biodegradable Gd‐doped microspheres can be effectively used to deliver drugs in a sustained manner, while being monitored noninvasively with MRI. Magn Reson Med 51:1265–1271, 2004. Published 2004 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


In vitro characterization of hepatocyte
✍ Xin Hao Zhu; Chi-Hwa Wang; Yen Wah Tong 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 468 KB 👁 1 views

## Abstract Polymer scaffolds which can support cells to grow as well as deliver growth factors to the cells simultaneously have great potential for the successful regeneration of failed tissues. As popularly used vehicles to deliver anti‐cancer drugs and growth factors, microspheres also show many

In vitro growth factor release from inje
✍ W. J. E. M. Habraken; O. C. Boerman; J. G. C. Wolke; A. G. Mikos; J. A. Jansen 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 403 KB 👁 1 views

## Abstract To improve the __in vivo__ resorption of an injectable calcium phosphate cement (CPC) for bone tissue engineering purposes, in previous experiments macroporosity was introduced by the __in situ__ degradation of incorporated gelatin microspheres. Gelatin microspheres are also suitable ca

Vascular endothelial growth factor (VEGF
✍ Michael S. Pepper; Stefano J. Mandriota; Michael Jeltsch; Vijay Kumar; Kari Alit 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 689 KB

Vascular endothelial growth factor-C (VEGF-C) is a recently characterized member of the VEGF family of angiogenic polypeptides. We demonstrate here that VEGF-C is angiogenic in vitro when added to bovine aortic or lymphatic endothelial (BAE and BLE) cells but has little or no effect on bovine microv

Effect of controlled release of fibrobla
✍ Shingo Nakamura; Masaki Nambu; Takamitsu Ishizuka; Hidemi Hattori; Yasuhiro Kana 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 316 KB 👁 2 views

## Abstract We produced a chitosan/fucoidan micro complex‐hydrogel as a carrier for controlled release of heparin binding growth factors such as fibroblast growth factor (FGF)‐2. Material consisting of a soluble chitosan (CH‐LA) mixed with fucoidan yielded a water‐insoluble and injectable hydrogel

Hyaluronic acid modulates gene expressio
✍ Yu-Tsang Lee; Hung-Jen Shao; Jyh-Horng Wang; Haw-Chang Liu; Sheng-Mou Hou; Tai-H 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 275 KB

Intraarticular injection of hyaluronan (hyaluronic acid; HA) is the common way to treat osteoarthritis (OA) of knees. This treatment cannot only maintain the viscoelastic properties of knee but also release the OA pain. However, the exact molecular mechanism is unknown. In this study, after human sy

Hypoxic response elements control expres
✍ Bo Jiang; Hongyan Dong; Zhongming Zhang; Wei Wang; Yiqian Zhang; Xiahong Xu 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 406 KB

## Abstract ## Background Vascular endothelial growth factor (VEGF) gene transfer with recombinant adeno‐associated viral (rAAV) vector for ischemia heart disease therapy is being increasingly studied. However, uncontrolled long‐term expression of VEGF may cause some side effects. Therefore, an at